Immediate Impact
2 by Nobel laureates 60 standout
Citing Papers
Surviving Sepsis Campaign Research Priorities 2023
2024 Standout
mRNA-based therapeutics: looking beyond COVID-19 vaccines
2024 StandoutNobel
Works of Kathy Cullen being referenced
Keratinocyte growth factor for the treatment of the acute respiratory distress syndrome (KARE): a randomised, double-blind, placebo-controlled phase 2 trial
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Kathy Cullen | 72 | 26 | 40 | 83 | 16 | 198 | |
| Gilson Fernandes Ruivo | 16 | 32 | 30 | 58 | 12 | 147 | |
| Masahiro Ryu | 26 | 64 | 11 | 82 | 21 | 261 | |
| Aldo Guerrieri | 123 | 23 | 63 | 32 | 16 | 252 | |
| Takae Matsushita | 90 | 82 | 23 | 109 | 12 | 244 | |
| Konstantina Dimakou | 45 | 9 | 12 | 42 | 11 | 197 | |
| Shubhdeep Kaur | 11 | 21 | 28 | 153 | 13 | 247 | |
| Adam D. Lindsay | 60 | 9 | 10 | 36 | 19 | 274 | |
| Miguel García González | 52 | 19 | 33 | 24 | 20 | 151 | |
| María‐Victoria Mateos‐Moreno | 17 | 13 | 19 | 95 | 19 | 252 | |
| Esma Kürklü | 48 | 10 | 22 | 53 | 18 | 248 |
All Works
Login with ORCID to disown or claim papers
Loading papers...